Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs 
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown 
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case 
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
LAKE FOREST, Calif., April 06, 2017 -- InMode Aesthetic Solutions®, a leader in aesthetic medicine and technology, is proud to announce the launch of the brand’s newest procedure, BodyTite. This non-excisional device utilizes radio-frequency assisted lipolysis (RFAL) to address the shortcomings often associated with traditional liposuction or surgical body and face lifts, including sagging or wrinkly skin and scarring, by inserting a wand under the skin to coagulate inside while tightening the skin on top.
With over one hundred surgical practices in North America already utilizing the new technology, doctors can ensure their patients receive surgical-like procedures with limited downtime and without scars. The FDA approved technology, for use on the stomach, arms, chest, knees and inner/outer thighs, is minimally invasive and leaves virtually no scarring. Results can be seen immediately after one treatment and are more evident over three to six months post-treatment.
Previously, patients looking for fat reduction treatments had limited options including multiple non-invasive treatments with limited skin contraction results, a surgical tummy tuck with downtime or a brachioplasty, leaving large excision scars. These options left patients who wanted less invasive procedures without a solution, or unhappy with the results of their treatment. With BodyTite, doctors are able to ensure patients receive minimally invasive, effective procedures and offer powerful aesthetic results.
“Traditional surgery can leave permanent scars, and does not really fix the problem -- soft tissue with no internal support framework,” Diane Duncan, M.D., Fort Collins CO, a practitioner of BodyTite explains. “This new device is providing that internal structure reorganization, and in addition, has been proven to create up to 36.4% skin surface area contraction at one year” (Duncan, Aesthetic Surgery Journal, 2016).
“BodyTite is one of many technological innovations to come from InMode this year,” says Erik Dowell, CEO of InMode North America. “With our enhanced management team, we are looking forward to showcasing the advances we are making to the cosmetic industry to doctors and patients alike.”
About InMode: InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.
Press Contact: Gianna Visconti | The Woods & Co [email protected] | 212.838.1878
